Metropolitan Life Insurance CO Recursion Pharmaceuticals, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$9.13 - $15.52 $5,770 - $9,808	-632 Reduced 7.98%	7,290 $72,000
Q3 2023 Nov 14, 2023	BUY	$6.59 - $15.86 $2,458 - $5,915	373 Added 4.94%	7,922 $60,000
Q1 2023 May 15, 2023	SELL	$6.42 - $9.64 $5,302 - $7,962	-826 Reduced 9.86%	7,549 $50,000
Q4 2022 Jun 14, 2023	BUY	$7.16 - $12.7 $5,914 - $10,490	826 Added 10.94%	8,375 $64.6 Million
Q3 2022 Jun 14, 2023	BUY	$7.83 - $13.6 $6,467 - $11,233	826 Added 10.94%	8,375 $89.1 Million
Q2 2022 Jun 20, 2023	BUY	$5.04 - $9.26 $4,163 - $7,648	826 Added 10.94%	8,375 $68,000
Q2 2022 Mar 30, 2023	BUY	$5.04 - $9.26 $3,457 - $6,352	686 Added 8.92%	8,375 $68,000
Q2 2022 Aug 11, 2022	BUY	$5.04 - $9.26 $3,457 - $6,352	686 Added 8.92%	8,375 $68,000
Q1 2022 Jun 20, 2023	BUY	$6.16 - $18.03 $862 - $2,524	140 Added 1.85%	7,689 $55,000
Q1 2022 Mar 30, 2023	SELL	$6.16 - $18.03 $140,651 - $411,678	-22,833 Reduced 74.81%	7,689 $55,000
Q1 2022 May 12, 2022	SELL	$6.16 - $18.03 $140,651 - $411,678	-22,833 Reduced 74.81%	7,689 $55,000
Q4 2021 Jun 21, 2023	BUY	$16.14 - $21.86 $370,784 - $502,189	22,973 Added 304.32%	30,522 $522,000
Q4 2021 Mar 30, 2023	BUY	$16.14 - $21.86 $361,342 - $489,401	22,388 Added 275.24%	30,522 $522,000
Q4 2021 Feb 15, 2022	BUY	$16.14 - $21.86 $361,342 - $489,401	22,388 Added 275.24%	30,522 $523,000
Q3 2021 Jun 21, 2023	BUY	$19.03 - $41.33 $11,132 - $24,178	585 Added 7.75%	8,134 $187,000
Q3 2021 Mar 30, 2023	BUY	$19.03 - $41.33 $27,917 - $60,631	1,467 Added 22.0%	8,134 $187,000
Q3 2021 Nov 15, 2021	BUY	$19.03 - $41.33 $27,917 - $60,631	1,467 Added 22.0%	8,134 $187,000
Q2 2021 Jun 21, 2023	SELL	$18.0 - $37.42 $15,876 - $33,004	-882 Reduced 11.68%	6,667 $243,000
Q2 2021 Mar 30, 2023	SELL	$18.0 - $37.42 $30,744 - $63,913	-1,708 Reduced 20.39%	6,667 $243,000
Q2 2021 Aug 16, 2021	BUY	$18.0 - $37.42 $120,006 - $249,479	6,667 New	6,667 $243,000

Others Institutions Holding RXRX

# of Institutions

286

Shares Held

242M

Call Options Held

1.35M

Put Options Held

2.32M

Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

32.8M
Shares

$203 Million
2.05% of portfolio
Baillie Gifford & CO

25.2M
Shares

$156 Million
0.13% of portfolio
Vanguard Group Inc Valley Forge, PA

24.3M
Shares

$150 Million
0.0% of portfolio
Black Rock Inc. New York, NY

17.3M
Shares

$107 Million
0.0% of portfolio
Ra Capital Management, L.P. Boston, MA

15.4M
Shares

$95.1 Million
1.41% of portfolio

View Full List

About RECURSION PHARMACEUTICALS, INC.

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.12B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

More about RXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account